PMH9 ESTIMATED COST-EFFECTIVENESS OF A 12-WEEK TREATMENT COURSE OF THE FIRST FDA-CLEARED PRESCRIPTION DIGITAL THERAPEUTIC FOR PATIENTS WITH OPIOID USE DISORDER
May 1, 2020, 00:00 AM
10.1016/j.jval.2020.04.630
https://www.valueinhealthjournal.com/article/S1098-3015(20)30818-4/fulltext
Section Title :
Section Order :
10524
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(20)30818-4&doi=10.1016/j.jval.2020.04.630